Hiscutt, Emma L <br/><br/>
Targeting X-linked inhibitor of apoptosis protein to increase the efficacy of endoplasmic reticulum stress-induced apoptosis for melanoma therapy.  [electronic resource] 

 -  The Journal of investigative dermatology  Sep 2010 
 - 2250-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1523-1747 
<br/><br/><label>Standard No.: </label>10.1038/jid.2010.146  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Boronic Acids--pharmacology<br/>Bortezomib<br/>Drug Resistance, Neoplasm<br/>Endoplasmic Reticulum--physiology<br/>Female<br/>Fenretinide--pharmacology<br/>Gene Expression Regulation, Neoplastic<br/>Genes, ras--physiology<br/>Humans<br/>In Vitro Techniques<br/>Male<br/>Melanoma--drug therapy<br/>Middle Aged<br/>Mutation--genetics<br/>Nevus, Pigmented--drug therapy<br/>Proto-Oncogene Proteins B-raf--genetics<br/>Pyrazines--pharmacology<br/>RNA, Small Interfering<br/>Skin Neoplasms--drug therapy<br/>Stress, Physiological--physiology<br/>X-Linked Inhibitor of Apoptosis Protein--antagonists & inhibitors